Hematology and Medical Oncology Practice Updates and Board Review 2025
Designed to provide attendees with up-to-date, practical information and best practices that can be applied immediately into daily clinical practice
Designed to provide attendees with up-to-date, practical information and best practices that can be applied immediately into daily clinical practice
Offers a timely opportunity to explore the latest breakthroughs and emerging trends driving the future of agricultural biotechnology.
MD&M West offers attendees an event experience like no other, delivering the pinnacle in cutting-edge components and technology.
The Pharma Market Research Conference is the key to uncovering knowledge and developing new business relationships.
It showcase the latest innovations in AI integration, novel reimbursement avenues and alternative regulatory pathways to achieve commercial viability.
Liquid biopsy testing has continued to revolutionize diagnostics and personalized medicine; from the integration of AI and automation to elevate liquid biopsy capabilities, to the approval of MRD as an endpoint in Multiple Myeloma.
Servier’s recent approval of vorasidenib for Grade 2 IDH-mutant glioma has sparked renewed hope in a space that has long struggled with limited treatment options.
A dedicated forum to advancing novel radiopharmaceutical drug discovery. Delve deep into target mining, screening, discovery and selection from ROR1, uPAR, B7-H3, NECTIN-4, CAIX and more.
This year’s all-new agenda offers unprecedented detail on optimizing digital innovation, working with regulatory and legal review partners, and exploring how to establish a culture on innovation.
As the NK community remains determined as ever to prove the advantages of NK cells, the year of the ‘bounce back’ now feels within reach.